MedImmune to Announce 2006 Fourth Quarter and Year-End Financial Results on February 7, 2007
2007年1月11日 - 5:26AM
PRニュース・ワイアー (英語)
GAITHERSBURG, Md., Jan. 10 /PRNewswire-FirstCall/ -- MedImmune,
Inc.'s (NASDAQ:MEDI) 2006 fourth-quarter and year-end financial
results are expected to be released on Wednesday, February 7, 2007
before the opening of the U.S. financial markets. The company is
also planning to host a conference call and live audio webcast at
8:00 a.m. eastern time following the announcement. During the
conference call, MedImmune's management will discuss the financial
results and other business. The press release and the live webcast
can be accessed by going to the Investor Relations section of the
MedImmune website at http://www.medimmune.com/. An archived version
of the call will be available at the same address for one week
after the live webcast. About MedImmune MedImmune strives to
provide better medicines to patients, new medical options for
physicians, rewarding careers to employees, and increased value to
shareholders. Dedicated to advancing science and medicine to help
people live better lives, the company is focused on the areas of
infectious diseases, cancer and inflammatory diseases. With more
than 2,500 employees worldwide, MedImmune is headquartered in
Maryland. For more information, visit the company's website at
http://www.medimmune.com/. This announcement contains
forward-looking statements including that the company expects to
disseminate financial information for the fourth quarter and
year-end of 2006. Such statements reflect management's current
views and are based on certain assumptions, including but not
limited to, completion of the company's quarter-end and year-end
closing procedures and completion of certain quarter-end and
year-end review procedures. There can be no assurance that such
procedures will be completed in the timeframe allotted or for those
reasons or any others, that the company will not choose to
disseminate such financial information on a different date and/or
time. DATASOURCE: MedImmune, Inc. CONTACT: Investors: Peter Vozzo,
+1-301-398-4358, or Media: Jamie Lacey, +1-301-398-4035, both of
MedImmune, Inc. Web site: http://www.medimmune.com/
Copyright
Medimmune (NASDAQ:MEDI)
過去 株価チャート
から 12 2024 まで 1 2025
Medimmune (NASDAQ:MEDI)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Medimmune (MM) (ナスダック市場): 0 recent articles
その他のMedimmune (MM)ニュース記事